86 related articles for article (PubMed ID: 10781813)
21. Vav: Captain Hook for signal transduction?
Katzav S
Crit Rev Oncog; 1995; 6(2):87-97. PubMed ID: 8792085
[TBL] [Abstract][Full Text] [Related]
22. The haematopoietic specific signal transducer Vav1 is expressed in a subset of human neuroblastomas.
Hornstein I; Pikarsky E; Groysman M; Amir G; Peylan-Ramu N; Katzav S
J Pathol; 2003 Apr; 199(4):526-33. PubMed ID: 12635144
[TBL] [Abstract][Full Text] [Related]
23. Novel recognition mode between Vav and Grb2 SH3 domains.
Nishida M; Nagata K; Hachimori Y; Horiuchi M; Ogura K; Mandiyan V; Schlessinger J; Inagaki F
EMBO J; 2001 Jun; 20(12):2995-3007. PubMed ID: 11406576
[TBL] [Abstract][Full Text] [Related]
24. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
Groysman M; Nagano M; Shaanan B; Katzav S
Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237
[TBL] [Abstract][Full Text] [Related]
25. Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products.
Toksoz D; Williams DA
Oncogene; 1994 Feb; 9(2):621-8. PubMed ID: 8290273
[TBL] [Abstract][Full Text] [Related]
26. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation.
Michel F; Mangino G; Attal-Bonnefoy G; Tuosto L; Alcover A; Roumier A; Olive D; Acuto O
J Immunol; 2000 Oct; 165(7):3820-9. PubMed ID: 11034388
[TBL] [Abstract][Full Text] [Related]
27. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Heo J; Thapar R; Campbell SL
Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine phosphorylation of the proto-oncogene product Vav and its association with the adapter Grb2/Ash in a human leukemia cell line UT-7.
Hanazono Y; Sasaki K; Odai H; Mimura T; Mitani K; Yazaki Y; Hirai H
Jpn J Cancer Res; 1995 Apr; 86(4):336-41. PubMed ID: 7539782
[TBL] [Abstract][Full Text] [Related]
29. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes.
Ramos-Morales F; Druker BJ; Fischer S
Oncogene; 1994 Jul; 9(7):1917-23. PubMed ID: 8208538
[TBL] [Abstract][Full Text] [Related]
30. Cross-linking of integrins induces tyrosine phosphorylation of the proto-oncogene product Vav and the protein tyrosine kinase Syk in human factor-dependent myeloid cells.
Gotoh A; Takahira H; Geahlen RL; Broxmeyer HE
Cell Growth Differ; 1997 Jun; 8(6):721-9. PubMed ID: 9186005
[TBL] [Abstract][Full Text] [Related]
31. The proline-rich region of Vav binds to Grb2 and Grb3-3.
Ramos-Morales F; Romero F; Schweighoffer F; Bismuth G; Camonis J; Tortolero M; Fischer S
Oncogene; 1995 Oct; 11(8):1665-9. PubMed ID: 7478592
[TBL] [Abstract][Full Text] [Related]
32. The high transforming potency of erbB-2 and ret is associated with phosphorylation of paxillin and a 23 kDa protein.
Romano A; Wong WT; Santoro M; Wirth PJ; Thorgeirsson SS; Di Fiore PP
Oncogene; 1994 Oct; 9(10):2923-33. PubMed ID: 7916147
[TBL] [Abstract][Full Text] [Related]
33. Expression of vav proto-oncogene by nonhematopoietic trophoblast cells at the human uteroplacental interface.
Higuchi T; Kanzaki H; Fujimoto M; Hatayama H; Watanabe H; Fukumoto M; Kaneko Y; Higashitsuji H; Kishishita M; Mori T
Biol Reprod; 1995 Oct; 53(4):840-6. PubMed ID: 8547479
[TBL] [Abstract][Full Text] [Related]
34. Binding of Vav to Grb2 through dimerization of Src homology 3 domains.
Ye ZS; Baltimore D
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12629-33. PubMed ID: 7809090
[TBL] [Abstract][Full Text] [Related]
35. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.
Tarakhovsky A; Turner M; Schaal S; Mee PJ; Duddy LP; Rajewsky K; Tybulewicz VL
Nature; 1995 Mar; 374(6521):467-70. PubMed ID: 7700358
[TBL] [Abstract][Full Text] [Related]
36. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
37. Expression of a novel isoform of Vav, Vav-T, containing a single Src homology 3 domain in murine testicular germ cells.
Okumura K; Kaneko Y; Nonoguchi K; Nishiyama H; Yokoi H; Higuchi T; Itoh K; Yoshida O; Miki T; Fujita J
Oncogene; 1997 Feb; 14(6):713-20. PubMed ID: 9038379
[TBL] [Abstract][Full Text] [Related]
38. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42.
Movilla N; Dosil M; Zheng Y; Bustelo XR
Oncogene; 2001 Dec; 20(56):8057-65. PubMed ID: 11781818
[TBL] [Abstract][Full Text] [Related]
39. Mutation of Vav1 adaptor region reveals a new oncogenic activation.
Razanadrakoto L; Cormier F; Laurienté V; Dondi E; Gardano L; Katzav S; Guittat L; Varin-Blank N
Oncotarget; 2015 Feb; 6(4):2524-37. PubMed ID: 25426554
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
